EssilorLuxottica, Hôpital Fondation Adolphe de Rothschild, Inria, InSimo, IMT and Institut de la Vision have joined forces to launch PREMYOM (Prise en charge et Ralentissement de l’Epidémie de MYopie par l’Optique Médicale1). This five-year research and innovation project aims to set a new standard in the med-tech dimension with personalized myopia treatment through medical optics.
Bringing together technical, clinical and digital expertise from leading healthcare, research and industry organizations, PREMYOM will provide a better understanding of the clinical and biological mechanisms behind myopia progression to deliver advanced, personalized ophthalmic solutions tailored to individual needs.